135 related articles for article (PubMed ID: 35702575)
41. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 M
More-Adate P; Lokhande KB; Swamy KV; Nagar S; Baheti A
Comput Biol Med; 2022 Aug; 147():105679. PubMed ID: 35667152
[TBL] [Abstract][Full Text] [Related]
42. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
Vardhan S; Sahoo SK
Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
[TBL] [Abstract][Full Text] [Related]
43. Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M
Bharadwaj KK; Sarkar T; Ghosh A; Baishya D; Rabha B; Panda MK; Nelson BR; John AB; Sheikh HI; Dash BP; Edinur HA; Pati S
Appl Biochem Biotechnol; 2021 Oct; 193(10):3371-3394. PubMed ID: 34212286
[TBL] [Abstract][Full Text] [Related]
44. In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.
Gajjar ND; Dhameliya TM; Shah GB
J Mol Struct; 2021 Sep; 1239():130488. PubMed ID: 33903778
[TBL] [Abstract][Full Text] [Related]
45. Prophylactic and Therapeutic Potential Zinc Metallodrugs Drug Discovery: Identification of SARS-CoV-2 Replication and Spike/ACE2 Inhibitors.
Ngoepe MP; Tapala KC; Clayton HS
Curr Comput Aided Drug Des; 2022; 18(7):519-534. PubMed ID: 36154578
[TBL] [Abstract][Full Text] [Related]
46. In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV.
Shaikh IA; Muddapur UM; C K; Badiger S; Kulkarni M; Mahnashi MH; Alshamrani SA; Huneif MA; More SS; Khan AA; Iqubal SMS
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268612
[TBL] [Abstract][Full Text] [Related]
47. In silico screening of the effectiveness of natural compounds from algae as SARS-CoV-2 inhibitors: molecular docking, ADMT profile and molecular dynamic studies.
Mohammed Ali HSH; Altayb HN; Bayoumi AAM; El Omri A; Firoz A; Chaieb K
J Biomol Struct Dyn; 2023 Apr; 41(7):3129-3144. PubMed ID: 35253618
[TBL] [Abstract][Full Text] [Related]
48. Natural compounds from
Kar P; Sharma NR; Singh B; Sen A; Roy A
J Biomol Struct Dyn; 2021 Aug; 39(13):4774-4785. PubMed ID: 32552595
[TBL] [Abstract][Full Text] [Related]
49. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
[TBL] [Abstract][Full Text] [Related]
50. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
[TBL] [Abstract][Full Text] [Related]
51. Potential of Marine Terpenoids against SARS-CoV-2: An
Sahoo A; Fuloria S; Swain SS; Panda SK; Sekar M; Subramaniyan V; Panda M; Jena AK; Sathasivam KV; Fuloria NK
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829734
[TBL] [Abstract][Full Text] [Related]
52.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
53. Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro.
Bibi S; Khan MS; El-Kafrawy SA; Alandijany TA; El-Daly MM; Yousafi Q; Fatima D; Faizo AA; Bajrai LH; Azhar EI
Saudi Pharm J; 2022 Jul; 30(7):979-1002. PubMed ID: 35637849
[TBL] [Abstract][Full Text] [Related]
54.
Patil SM; Martiz RM; Ramu R; Shirahatti PS; Prakash A; Chandra S J; Ranganatha VL
J Biomol Struct Dyn; 2022; 40(23):13032-13048. PubMed ID: 34632942
[TBL] [Abstract][Full Text] [Related]
55. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
Elkaeed EB; Eissa IH; Elkady H; Abdelalim A; Alqaisi AM; Alsfouk AA; Elwan A; Metwaly AM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955547
[TBL] [Abstract][Full Text] [Related]
56. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
[TBL] [Abstract][Full Text] [Related]
57. Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-
Suleimen YM; Jose RA; Mamytbekova GK; Suleimen RN; Ishmuratova MY; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Plants (Basel); 2022 Aug; 11(15):. PubMed ID: 35956550
[TBL] [Abstract][Full Text] [Related]
58. Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors.
Fouedjou RT; Chtita S; Bakhouch M; Belaidi S; Ouassaf M; Djoumbissie LA; Tapondjou LA; Abul Qais F
J Biomol Struct Dyn; 2022; 40(19):8615-8629. PubMed ID: 33908318
[TBL] [Abstract][Full Text] [Related]
59. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
Dhankhar P; Dalal V; Kumar V
J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
[TBL] [Abstract][Full Text] [Related]
60. Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19.
Bhati S
Heliyon; 2020 Nov; 6(11):e05558. PubMed ID: 33251371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
